Melissa Majerol
Associate Director, Oncology Policy Strategy, AstraZeneca
Melissa Majerol is listed as Associate Director, Oncology Policy Strategy, AstraZeneca. Melissa is scheduled to speak at World Evidence, Pricing and Access Congress USA on 14 September 2027.
Compiled from published conference agendas; not yet confirmed by Melissa. Is this you? Claim this profile.
Upcoming
World Evidence, Pricing and Access Congress USA 14 September 2027 – 15 September 2027
Announced as a speaker.
Others from AstraZeneca
- Paul Hudson President, AstraZeneca US and Executive Vice President, North America 5 sessions
- Jarosław Oleszczuk Speaker 4 sessions
- Shaun Grady Chair of AstraZeneca UK 4 sessions
- Gabriel Wong Senior Director Physician, Clinical Research, Immunology 3 sessions
- Olga Obrezanova Principal Scientist, Augmented Biologics Design 3 sessions
- Agnieszka Jozwik Senior Research Scientist, Functional Genomics 2 sessions
- Christof Jaeger Senior Director - Data Science & Modelling - Substance, Pharmaceutical Sciences 2 sessions
- Goran Dahl Associate Principal Scientist 2 sessions
- James Fleming Scientist 2 sessions
- Jarrod Walsh Director of Biochemical & Biophysical Screening 2 sessions
- Melanie Leveridge Vice President Assays, Profiling & Cell Sciences 2 sessions
- Miranda Cooper Statistical Science Director 2 sessions